Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Oligonucleotides: State of the Art
Smith Rjh, Rula Zain
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 605-630
Closed Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 400
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery
Yuchen Fan, Maria Marioli, Kelly Zhang
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 192, pp. 113642-113642
Closed Access | Times Cited: 282
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 231
Transfection types, methods and strategies: a technical review
Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho
PeerJ (2021) Vol. 9, pp. e11165-e11165
Open Access | Times Cited: 187
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein, Patrick Garidel
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 11, pp. 1205-1226
Closed Access | Times Cited: 168
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 161
Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
Pedro Pires Goulart Guimarães, Rui Zhang, Roman Spektor, et al.
Journal of Controlled Release (2019) Vol. 316, pp. 404-417
Open Access | Times Cited: 160
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 129
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Sachin S. Shivatare, Vidya S. Shivatare, Chi‐Huey Wong
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15603-15671
Open Access | Times Cited: 112
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
Julia M. Migliorati, Sunna Liu, Anna Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 888-897
Open Access | Times Cited: 74
CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
Liangliang Hao, Renee T. Zhao, Nicole L. Welch, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 7, pp. 798-807
Open Access | Times Cited: 67
Antisense oligonucleotides: a novel Frontier in pharmacological strategy
Debora Collotta, Ilaria Bertocchi, E. Chiapello, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 61
Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs
Hideo Takakusa, Norihiko Iwazaki, Makiya Nishikawa, et al.
Nucleic Acid Therapeutics (2023) Vol. 33, Iss. 2, pp. 83-94
Open Access | Times Cited: 56
Aptamer-Based Targeted Protein Degradation
Yuan Liu, Xu Qian, Chunyan Ran, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6150-6164
Open Access | Times Cited: 49
Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols
Stefano Giordani, Valentina Marassi, Andrea Zattoni, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115751-115751
Open Access | Times Cited: 46
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 25
Modified nucleic acids: replication, evolution, and next-generation therapeutics
Karen E. Duffy, Sebastian Arangundy‐Franklin, Philipp Holliger
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 118
Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
Lisa Hobuß, Christian Bär, Thomas Thum
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 115
A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives
Yujie Shi, Lu An, Xiangyu Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2396-2415
Open Access | Times Cited: 101
Characterization of therapeutic oligonucleotides by liquid chromatography
Alexandre Goyon, Peter Yehl, Kelly Zhang
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 182, pp. 113105-113105
Closed Access | Times Cited: 98
A new dawn for managing dyslipidemias: The era of rna-based therapies
Chiara Macchi, Cesare R. Sirtori, Alberto Corsini, et al.
Pharmacological Research (2019) Vol. 150, pp. 104413-104413
Open Access | Times Cited: 86
Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
Hao Cui, Xinying Zhu, Shuyue Li, et al.
ACS Omega (2021) Vol. 6, Iss. 25, pp. 16259-16265
Open Access | Times Cited: 84
Mass Spectrometry of Nucleic Acid Noncovalent Complexes
Eric Largy, Alexander König, Anirban Ghosh, et al.
Chemical Reviews (2021) Vol. 122, Iss. 8, pp. 7720-7839
Open Access | Times Cited: 75
Chemistry of Peptide-Oligonucleotide Conjugates: A Review
Kristina Klabenkova, А. А. Фокина, Dmitry A. Stetsenko
Molecules (2021) Vol. 26, Iss. 17, pp. 5420-5420
Open Access | Times Cited: 67
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top